Table 1 The correlations between G2E3 expression and clinicopathological characteristics
Variables | G2E3 positive (%) | G2E3 negative (%) | p-value |
|---|---|---|---|
No. of patients | 58 (37.2) | 98 (62.8) | Â |
Age | Â | Â | 0.185 |
 ≤ 45 | 49 (84.5) | 74 (75.5) |  |
 > 45 | 9 (15.5) | 24 (24.5) |  |
T grade | Â | Â | 0.537 |
 1 | 13 (22.4) | 19 (19.4) |  |
 2 | 44 (75.9) | 74 (75.5) |  |
 3 | 1 (1.7) | 5 (5.1) |  |
N grade | Â | Â | 0.055 |
 0 | 25 (43.1) | 59 (60.2) |  |
 1 | 15 (25.9) | 23 (23.5) |  |
 2 | 6 (10.3) | 9 (9.2) |  |
 3 | 12 (20.7) | 7 (7.1) |  |
Histological grade | Â | Â | 0.885 |
 1 | 2 (3.4) | 5 (5.1) |  |
 2 | 42 (72.4) | 69 (70.4) |  |
 3 | 14 (24.1) | 24 (24.5) |  |
Subtypes | Â | Â | 0.050 |
 Luminal | 39 (67.2) | 52 (53.1) |  |
 HER2 positive | 13 (22.4) | 20 (20.4) |  |
 Triple negative | 6 (10.4) | 26 (26.5) |  |
Menopausal status | Â | Â | 0.668 |
 Premenopausal | 24 (41.4) | 44 (44.9) |  |
 Postmenopausal | 34 (58.6) | 54 (55.1) |  |
Relapse/distant organ metastasis | Â | Â | < 0.001 |
 Yes | 28 (48.3) | 21 (21.4) |  |
 No | 30 (51.7) | 77 (78.6) |  |
Death | Â | Â | 0.048 |
 Yes | 18 (31.0) | 17 (17.3) |  |
 No | 40 (69.0) | 81 (82.7) |  |